Rick Doblin

Rick Doblin: Psychedelics | Lex Fridman Podcast #202

Rick Doblin, Lex Fridman

Led by Rick Doblin, the Multidisciplinary Association for Psychedelic Studies (MAPS) has achieved Phase 3 trial results showing MDMA-assisted therapy is significantly more effective than placebo and existing antidepressants for treating severe PTSD. The organization's unique non-profit structure and regulatory strategy leverage a 1984 data exclusivity bill to fund the development of these drugs while avoiding patent monopolies, positioning MAPS to potentially approve MDMA for clinical use in late 2023. This initiative aims to fundamentally transform mental healthcare by shifting the global paradigm from prohibition to therapeutic integration, with projected licensed legalization for supervised personal use by 2035.